Links for Medical Professionals
Movicol (also known as Macrogol, PEG3350)
- Medsafe Data Sheet - Movicol.
- Treatment of faecal impaction with polyethelene glycol plus electrolytes (PGE + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy.
- PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial.
- Treatment of faecal impaction with polyethelene glycol plus electrolytes (PGE + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy.
- Macrogol (polyethylene glycol) laxatives in children with functional constipation and faecal impaction: a systematic review.
- A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence.
Encopresis
- Outcome of functional constipation in childhood: a 10-year follow-up study.
- Diagnosis and treatment of constipation in children.
- Toilet tales: stool toileting refusal, encopresis, and fecal incontinence.
- When the going gets tough: pediatric constipation and encopresis.
Enuresis
- Diagnosis and management of nocturnal enuresis.
- Nocturnal enuresis (bedwetting).
- The pathophysiology of enuresis in children and young adults.
- A population based study of 2,856 school-age children with urinary incontinence.
- Desmopressin 30 years in clinical use: a safety review.
- Symptoms of sleep-disordered breathing in children with nocturnal enuresis.
-
Does combination therapy with desmopressin and tolterodine improve the treatment outcomes of patients with monosymptomatic nocturnal enuresis? A randomized clinical controlled trial.